The body needs some cholesterol to maintain good health. But for those who need to reduce the risk of a heart attack or stroke, statin drugs lower ... analysis in the New England Journal of ...

Overall, a 20% decrease in LDL cholesterol was seen. Participants reported that they would have found more information on drug interactions ... make statins unavailable to non-insured or indigent ...

A UCLA study has outlined a new framework that researchers say would improve predictive power of genetics to determine how well a patient would respond to commonly prescribed medications as well as ...

The topline results from the Phase III trial found the treatment to be well tolerated with a reduction in low-density ...

A new study has outlined a new framework that researchers say would improve predictive power of genetics to determine how well a patient would respond to commonly prescribed medications as well as the ...

4, 2024 — In addition to lowering your cholesterol ... put them at risk for cardiovascular disease, a new ... Common Hair Loss and Prostate Drug May Also Cut Heart Disease Risk in Men and ...

Pharmacy benefits manager CVS Health has warned that the new PCSK9 inhibitor class of cholesterol-lowering drugs poses an unprecedented ... who cannot tolerate statins or who cannot reach ...

NewAmsterdam Pharma's obicetrapib demonstrates strong phase 3 results. Discover why NAMS stock could rise as further studies ...

A UCLA study has outlined a new framework that researchers say would improve predictive power of genetics to determine how ...

The cholesterol-lowering drug has been classed ... as well as for patients with non-inherited forms of high cholesterol who can’t meet treatment targets with a statin and PCSK9 inhibitor.

When I had my cholesterol checked in July, it was down to 6.2. But I still needed to reduce my bad cholesterol (LDL) score to avoid going on statins ... with Pact’s V60 New Kit (a blue ...